CRDL Cardiol Therapeutics Inc.

0.8738USD1.250 CAD · TSX-8.09%Mkt Cap: 111.57M USDP/E: —

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx,…